Report Detail

Medical Devices Viscosupplementation Devices - Medical Devices Pipeline Assessment, 2019

  • RnM3819980
  • |
  • 07 November, 2019
  • |
  • Global
  • |
  • 83 Pages
  • |
  • GlobalData
  • |
  • Medical Devices

Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Viscosupplementation Devices Overview

3 Products under Development

  • 3.1 Viscosupplementation Devices - Pipeline Products by Stage of Development
  • 3.2 Viscosupplementation Devices - Pipeline Products by Segment
  • 3.3 Viscosupplementation Devices - Pipeline Products by Territory
  • 3.4 Viscosupplementation Devices - Pipeline Products by Regulatory Path
  • 3.5 Viscosupplementation Devices - Pipeline Products by Estimated Approval Date
  • 3.6 Viscosupplementation Devices - Ongoing Clinical Trials

4 Viscosupplementation Devices - Pipeline Products under Development by Companies

  • 4.1 Viscosupplementation Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Viscosupplementation Devices - Pipeline Products by Stage of Development

5 Viscosupplementation Devices Companies and Product Overview

  • 5.1 Ampio Pharmaceuticals Inc Company Overview
  • 5.2 Anika Therapeutics Inc Company Overview
  • 5.3 Carticept Medical Inc Company Overview
  • 5.4 Chi2Gel Ltd. Company Overview
  • 5.5 Cocoon Biotech, Inc. Company Overview
  • 5.6 Flex Biomedical Inc Company Overview
  • 5.7 Herng Shan Co Ltd Company Overview
  • 5.8 Kalvista Pharmaceuticals Inc Company Overview
  • 5.9 KiOmed Pharma Company Overview
  • 5.10 Lineage Cell Therapeutics Inc Company Overview
  • 5.11 Medytox Inc Company Overview
  • 5.12 Moebius Medical Ltd Company Overview
  • 5.13 OPKO Health Inc Company Overview
  • 5.14 Shin Poong Pharm Co Ltd Company Overview
  • 5.15 University of Kansas Company Overview

6 Viscosupplementation Devices - Recent Developments

  • 6.1 Sep 09, 2019: Bioventus agrees to nationwide contract with UnitedHealthcare commercial plans
  • 6.2 Sep 09, 2019: KalVista Pharmaceuticals reports fiscal first quarter results
  • 6.3 Aug 22, 2019: Ampio Pharmaceuticals retains financial advisor and appoints Transaction Advisory Committee
  • 6.4 Aug 12, 2019: Bioventus launches DUROLANE SJ (1mL) in Australia and New Zealand; receives expanded indications for DUROLANE (3mL)
  • 6.5 Jul 31, 2019: Smith & Nephew second quarter and first half 2019 results
  • 6.6 Jul 24, 2019: Anika reports second quarter 2019 financial results
  • 6.7 Jul 17, 2019: OrthogenRx CEO awarded 2019 Entrepreneur of the Year
  • 6.8 Jul 08, 2019: Anika appoints James Loerop as executive vice president of business development and strategic planning
  • 6.9 May 21, 2019: New U.S. Patents granted for RegenLab
  • 6.10 May 13, 2019: Anika to showcase regenerative medicine and orthobiologics portfolio at the 12th Biennial International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine Congress
  • 6.11 May 07, 2019: Smith & Nephew: Change of registered office
  • 6.12 May 02, 2019: Smith & Nephew first quarter 2019 trading report
  • 6.13 May 02, 2019: Anika reports first quarter 2019 financial results
  • 6.14 Apr 30, 2019: Anika Therapeutics names Stephen Goldy as vice president of U.S. Sales
  • 6.15 Apr 22, 2019: KalVista Pharmaceuticals names Daniel B. Soland to board of directors
  • 6.16 Apr 03, 2019: Anika to highlight regenerative medicine and Orthobiologics Portfolio at 2019 Asia Pacific Orthopaedic Association Sports Meeting
  • 6.17 Mar 29, 2019: PolarityTE announces Richard Hague, formerly from Sanofi, Genzyme and recently Anika Therapeutics as Chief Operating Officer
  • 6.18 Mar 25, 2019: Smith & Nephew: Re-presented historical quarterly revenue analysis
  • 6.19 Mar 22, 2019: Seikagaku launches HyLink, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis in Italy
  • 6.20 Mar 18, 2019: Anika Therapeutics names Robert Richard as Vice President of research and development
  • 6.21 Mar 14, 2019: Kalvista Pharmaceuticals reports fiscal third quarter result
  • 6.22 Mar 06, 2019: Ampio updates regulatory status for Ampion
  • 6.23 Feb 21, 2019: Anika reports fourth quarter and full year 2018 financial results
  • 6.24 Feb 20, 2019: Smith & Nephew celebrates 18th year on FTSE4Good index
  • 6.25 Feb 08, 2019: Smith & Nephew: Directorate changes
  • 6.26 Feb 07, 2019: Smith & Nephew fourth quarter and full year 2018 results
  • 6.27 Feb 06, 2019: Ampio updates status of pivotal clinical trial of Ampion to be carried out under a SPA
  • 6.28 Feb 04, 2019: KYERON receives CE mark approval for
  • 6.29 Feb 01, 2019: KalVista Pharmaceuticals names Brian J. G. Pereira as Board Director
  • 6.30 Jan 29, 2019: Bioventus Launches DUROLANE in Malaysia and Selects Athrotech as Exclusive Distribution Partner
  • 6.31 Dec 14, 2018: KalVista Pharmaceuticals reports fiscal 2018 second quarter results
  • 6.32 Dec 13, 2018: Overland Park Surgical Suites first outpatient surgery center in region to offer robotics-assisted partial and total knee replacement surgery using the Navio surgical system
  • 6.33 Dec 10, 2018: StimLabs announces Department of Veterans Affairs (VA) And Department of Defense (DoD) Agreements
  • 6.34 Nov 01, 2018: Smith & Nephew third quarter 2018 trading report
  • 6.35 Oct 25, 2018: Susan M. Stalnecker named to Bioventus Board of Managers
  • 6.36 Oct 24, 2018: Anika Therapeutics announces Third Quarter 2018 Financial Results
  • 6.37 Oct 24, 2018: Anika Therapeutics names Susan Vogt as Board Director
  • 6.38 Oct 02, 2018: Bioventus Receives ANVISA Approval to Market DUROLANE in Brazil and Selects Pfizer as Exclusive Distribution Partner

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us

Viscosupplementation Devices - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Viscosupplementation Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Viscosupplementation Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Viscosupplementation Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Viscosupplementation Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Viscosupplementation Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Viscosupplementation Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date


Summary:
Get latest Market Research Reports on Viscosupplementation Devices. Industry analysis & Market Report on Viscosupplementation Devices is a syndicated market report, published as Viscosupplementation Devices - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Viscosupplementation Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$2,500.00
$5,000.00
$7,500.00
1,946.58
3,893.15
5,839.73
2,270.56
4,541.11
6,811.67
272,247.50
544,495.00
816,742.50
179,787.75
359,575.50
539,363.25
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report